ArticleCancers2026

Surgical Complexity and Perioperative Feasibility Following Neoadjuvant Chemotherapy, Chemoradiotherapy, or Chemoimmunotherapy in Stage II-III Non-Small Cell Lung Cancer: A Retrospective Single-Institution Study.

Hiroki Sakai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.